Predictive study on magnetic resonance imaging on tissue composition of benign prostatic hyperplasia
-
摘要: 目的:研究核磁共振成像(MRI)与良性前列腺增生(BPH)组织学成分的关系。方法:选取43例前列腺穿刺患者(均确认为BPH),穿刺前行核磁共振检查。穿刺标本进行腺体百分比测算,并记录各穿刺点的影像学信号强度,进行差异性分析。利用IMAGE J软件对MRI图像进行分析,判断腺体成分比,并与前列腺体积(TPV)、前列腺特异性抗原(PSA)、国际前列腺症状评分(IPSS)、残余尿量(RUV)等临床数据进行相关性分析。结果:腺瘤组、混合组、间质组在穿刺点/外周带信号比上存在显著性差异,提示腺体成分表现出较高的信号比而间质成分信号比较低。影像学图片中腺体成分比与PSA、TPV存在正相关性,与IPSS评分和RUV无明显相关性。结论:通过MRI检查,可以在临床上通过无创的方法,来判断增生部分的腺体比例,为治疗用药和决策提供帮助。Abstract: Objective: To study the predictive value of magnetic resonance imaging(MRI) signal intensity on benign prostatic hyperplasia(BPH) histological features. Method: Forty-three patients who accepted prostatic biopsy were recruited in this study. All these patients were confirmed as BPH by pathological examination. MRI was introduced before biopsy, and the signal intensity of transitional zone/peripheral zone were recorded as a parameter to be compared within 3 pathological groups(adenomatous, interstitial, mixed). The area ratio of adenomatous components were calculated with IMAGE J software to detect the relevance of clinical data such as prostatic specific antigen(PSA), total prostate volume(TPV), International Prostatic Symptom Score(IPSS), residual urine volume(RUV). Result: There are significant differences in signal intensity of transitional zone/peripheral zone within 3 pathological groups. High signal intensity represented abundant adenomatous tissue. The area ratios of adenomatous components were related to PSA and TPV, but not to IPSS and RUV.Conclusion: MRI, a non-invasive and useful tool to predict the pathological component of BPH, would be of benefit to medication and treatment strategy.
-
-
[1] Kaplan SA,O'Neill E,Lowe R,et al.Prevalence of Low Testosterone in Aging Men With Benign Prostatic Hyperplasia:Data From the Proscar Long-term Efficacy and Safety Study(PLESS)[J].Aging Male,2013,16(2):48-51.
[2] Liu Q,Zhu Y,Liu J,et al.Ultrasound Image Features of Intravesical Prostatic Protrusion Indicated Failure of Medication Therapy of Finasteride and Doxazosin in Patients With Benign Prostatic Hyperplasia(LUTS/BPH)[J].Int Urol Nephrol,2017,49(3):399-404.
[3] 张帆,左强,黄毅,等.核磁共振与超声融合成像引导下前列腺靶向穿刺对Gleason评分 ≥ 7分前列腺癌检出的临床意义[J].中国男科学杂志,2018,32(3):32-36.
[4] Kim EH,Vemana G,Johnson MH,et al.Magnetic resonance imaging-targeted vs.conventional transrectal ultrasound-guided prostate biopsy:single-institution,matched cohort comparison[J].Urol Oncol,2015,33(3):109.e1-e 6.
[5] 夏同礼,杨新宇,那彦群.良性前列腺增生的组织病理及临床意义[J].中华医学杂志,2004,84(1):29-31.
[6] Fukuta F,Masumori N,Mori M,et al.Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study[J].BJU Int,2012,110(7):1023-1029.
[7] Isen K,Sinik Z,Alkibay T,et al.Magnetic resonance imaging and morphometric histologic analysis of prostate tissue composition in predicting the clinical outcome of terazosin therapy in benign prostatic hyperplasia[J].Int J Urol,2001,8(2):42-48.
[8] McNeal J.Pathology of Benign Prostatic Hyperplasia.Insight into Etiology[M]//Lepor H,Walsh PC,eds.The Urologic Clinics of North America.17th ed.WB Saunders Company:Philadelphia,1990:477-486.
[9] Kim CK,Park BK,Han JJ,et al.Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones:preliminary results[J].J Comput Assist Tomogr,2007,31(3):449-454.
[10] Kyoda Y,Ichihara K,Hashimoto K,et al.Sustained density of neuroendocrine cells with aging precedes development of prostatic hyperplasia in spontaneously hypertensive rats[J].BMC Urol,2019,19(1):91-94.
-
计量
- 文章访问数: 453
- PDF下载数: 587
- 施引文献: 0